Aidapak Recalls Potassium Acid Phosphate Tablets Due to Labeling Error
Aidapak Services, LLC is recalling Potassium Acid Phosphate 500 mg tablets because they may have been mislabeled as Prednisone 20 mg.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Potassium Acid Phosphate, Tablet, 500 mg, NDC 00486111101, due to a labeling error. The recalled tablets may have been mislabeled as predniSONE, Tablet, 20 mg, NDC 00591544301.
The affected product is identified by Pedigree AD52778_34 and an expiration date of 5/20/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication for the specific NDC and pedigree codes listed above. If the product matches the description, they should stop using it and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- POTASSIUM ACID PHOSPHATE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00486111101.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- POTASSIUM ACID PHOSPHATE
- Tablet
- 500 mg has the following codes: Pedigree: AD52778_34
- EXP: 5/20/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- SevereFDA Recalls Potentially Mislabeled Losartan Potassium Tablets
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phosphorus Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Mislabeled Pantoprazole Sodium Tablets
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Losartan Potassium Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModeratePrednisone Tablets Recalled for Potential Label Mixup with Aspirin
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Phytonadione Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22